Related Experiment Videos
Oxcarbazepine, an antiepileptic agent
1School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston 02115, USA.
Clinical Therapeutics
|June 8, 2001
Summary
Oxcarbazepine is an effective antiepileptic drug for partial seizures, offering an alternative to carbamazepine with a simpler pharmacokinetic profile and fewer drug interactions. It shows promise for patients intolerant to existing treatments.
Area of Science:
- Neurology
- Pharmacology
Background:
- Epilepsy is a prevalent neurological disorder with limited treatment options.
- Current antiepileptic drugs often cause adverse drug reactions and interactions.
Purpose of the Study:
- To review the pharmacology and therapeutic applications of oxcarbazepine.
- To compare oxcarbazepine with carbamazepine in treating epilepsy.
Main Methods:
- Literature search of MEDLINE, International Pharmaceutical Abstracts, and EMBASE (1980-2000).
- Keywords: oxcarbazepine, carbamazepine, epilepsy, seizures.
Main Results:
- Oxcarbazepine demonstrated efficacy in animal models and human trials for partial and generalized tonic-clonic seizures.
- It has a simpler pharmacokinetic profile than carbamazepine, with less cytochrome P450 metabolism and lower protein binding.
- Clinical trials showed significant seizure reduction in adults and children, with common side effects including CNS and GI disturbances. Hyponatremia risk is increased compared to carbamazepine, but drug interactions are less frequent.
Conclusions:
- Oxcarbazepine is a viable alternative to carbamazepine for partial seizures, especially in patients with intolerance.
- Further research is needed on its use in nonseizure disorders and pharmacoeconomic comparisons.